Update on the impact of the JAK2 mutation on signalling pathways in myeloproliferative disorders.
Skoda
Radek
R
Experimental Hematology, Department of Research, University Hospital Basel, Basel, Switzerland. radek.skoda@unibas.ch
D000818:Animals; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics* / Q000378:metabolism; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000503:physiopathology*; D015398:Signal Transduction
D053614:Janus Kinase 2